Boston Scientific Corporation BSX recently entered into a definitive agreement to acquire Bolt Medical, Inc. — an intravascular lithotripsy (IVL) advanced laser-based platform developer. The ...

JPMorgan keeps an Overweight rating on Boston Scientific (BSX) with a $110 price target after the company announced an agreement to acquire the 74% stake of Bolt Medical not yet owned for $443M ...

Boston Scientific had previously held a 26% stake in the company, and said in a statement that it "initially developed the concept for the Bolt IVL system which helped establish Bolt Medical in 2019." ...

Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular lithotripsy advanced laser-based platform for the treatment ...

Boston Scientific Corporation has entered a definitive agreement to acquire the remaining 74% stake not yet owned in Bolt Medical, in a deal valued at up to $664m. The acquisition includes nearly ...

Boston Scientific has agreed to acquire the rest of Bolt Medical, the developer of an intravascular-lithotripsy, or IVL, laser-based platform for the treatment of coronary and peripheral artery ...

The recent acquisition of Bolt Medical positions Boston Scientific strongly within the intravascular lithotripsy (IVL) space, which is considered promising due to its low penetration rates ...

Boston Scientific said Wednesday it has agreed to acquire Bolt Medical, paying up to $664 million for the 74% of the cardiovascular company it does not own. The price consists of a $443 million ...

Boston Scientific initially developed the concept for the Bolt IVL system which helped establish Bolt Medical in 2019. As a strategic investor in Bolt Medical, Boston Scientific has an equity ...

Jan. 8, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular ...